Does Rallies show Form 4 insider transactions for CTEV?

Yes. Rallies tracks CTEV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CTEV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CTEV. It does not provide personalized investment advice.

CTEV (Claritev Corporation) Stock Analysis - Insider Trades

Claritev Corporation (CTEV) is a publicly traded Healthcare sector company. As of May 21, 2026, CTEV trades at $21.18 with a market cap of $279.92M and a P/E ratio of -1.19. CTEV moved +31.67% today. Year to date, CTEV is -28.07%; over the trailing twelve months it is -26.04%. Its 52-week range spans $11.50 to $74.07. Analyst consensus is strong buy with an average price target of $32.00. Rallies surfaces CTEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CTEV stock inside the company?

Recent CTEV insider activity includes Garis Douglas Michael bought 1.30K, Kim Michael bought 15.00K, O'Neil Tara bought 750, Kim Michael bought 30.00K, and Dalton Travis bought 15.38K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CTEV Key Metrics

Key financial metrics for CTEV
Metric	Value
Price	$21.18
Market Cap	$279.92M
P/E Ratio	-1.19
EPS	$-17.30
Dividend Yield	0.00%
52-Week High	$74.07
52-Week Low	$11.50
Volume	69
Avg Volume	0
Revenue (TTM)	$965.41M
Net Income	$-284.28M
Gross Margin	0.00%

Recent CTEV Insider Trades

Garis Douglas Michael bought 1.30K (~$23.00K) on Mar 16, 2026.
Kim Michael bought 15.00K (~$247.50K) on Mar 12, 2026.
O'Neil Tara bought 750 (~$9.74K) on Mar 2, 2026.
Kim Michael bought 30.00K (~$428.95K) on Feb 27, 2026.
Dalton Travis bought 15.38K (~$199.93K) on Feb 27, 2026.

Latest CTEV News

Claritev’s Shares Plunge 40.9% Near 52-Week Low After PHCS Novera Launch — May 15, 2026
Claritev Outlines Q4 Revenue Growth and 2026 Expansion Plans — Feb 24, 2026
Claritev Q4 loss widens to $4.88/share as revenue jumps 6.2% to $246.6M — Feb 24, 2026

CTEV Analyst Consensus

4 analysts cover CTEV: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.00.

Common questions about CTEV

Who is trading CTEV stock inside the company?: Recent CTEV insider activity includes Garis Douglas Michael bought 1.30K, Kim Michael bought 15.00K, O'Neil Tara bought 750, Kim Michael bought 30.00K, and Dalton Travis bought 15.38K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CTEV?: Yes. Rallies tracks CTEV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CTEV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CTEV. It does not provide personalized investment advice.